Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

R-CHOP Versus R-FC Followed by Maintenance with Rituximab Versus Interferon-Alfa: Outcome of the First Randomized Trial for Elderly Patients with Mantle Cell Lymphoma

J.C. Kluin-Nelemans, E. Hoster, J. Walewski, MD, S. Stilgenbauer, M.D., C. H. Geisler, C. Gisselbrecht, MD, U. Vehling-Kaiser, MD, J. K. Doorduijn, MD, M. Trneny, MD, B. Coiffier, MD, R. Forstpointner, MD, H. Tilly, MD, L. Kanz, MD, M. Szymczyk, MD, O. Hermine, MD, PhD, W. Klapper, MD, W. Hiddemann, MD, M. Unterhalt, PhD, M. H. Dreyling, MD

Blood (2011) 118 (21): 439.

https://doi.org/10.1182/blood.V118.21.439.439

Published: 2011

Journal Articles

Reduction of Combined Modality Treatment Intensity in Early Stage Hodgkin’s Lymphoma: Interim Analysis of the HD 10 Trial of the GHSG.

Volker Diehl, C. Brillant, A. Engert, J. Wolf, L. Nogova, R.-P. Mueller, H. Eich, H.K. Mueller-Hermelink, R. Herrmann, B. Doerken, L. Kanz, R. Greil, B. Pfistner, for the German Hodgkin′s lymphoma study group (GHSG), the Competence Network Malignant Lymphoma.

Blood (2004) 104 (11): 1307.

https://doi.org/10.1182/blood.V104.11.1307.1307

Published: 2004

Journal Articles

Ex vivo expansion of CD34+ peripheral blood progenitor cells: implications for the expansion of contaminating epithelial tumor cells

W Vogel, D Behringer, S Scheding, L Kanz, W Brugger

Blood (1996) 88 (7): 2707–2713.

https://doi.org/10.1182/blood.V88.7.2707.bloodjournal8872707

Published: 1996

Journal Articles

Developmental regulation of myeloid gene expression and demethylation during ex vivo culture of peripheral blood progenitor cells

M Lubbert, W Brugger, R Mertelsmann, L Kanz

Blood (1996) 87 (2): 447–455.

https://doi.org/10.1182/blood.V87.2.447.bloodjournal872447

Published: 1996

Journal Articles

Detection of cytomegalovirus DNA in CD34+ cells from blood and bone marrow

D von Laer, U Meyer-Koenig, A Serr, J Finke, L Kanz, AA Fauser, D Neumann- Haefelin, W Brugger, FT Hufert

Blood (1995) 86 (11): 4086–4090.

https://doi.org/10.1182/blood.V86.11.4086.bloodjournal86114086

Published: 1995

Journal Articles

Maintenance of transplantation potential in ex vivo expanded CD34(+)- selected human peripheral blood progenitor cells

R Henschler, W Brugger, T Luft, T Frey, R Mertelsmann, L Kanz

Blood (1994) 84 (9): 2898–2903.

https://doi.org/10.1182/blood.V84.9.2898.2898

Published: 1994

Journal Articles

Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin

W Brugger, R Henschler, S Heimfeld, RJ Berenson, R Mertelsmann, L Kanz

Blood (1994) 84 (5): 1421–1426.

https://doi.org/10.1182/blood.V84.5.1421.1421

Published: 1994

Journal Articles

Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors [see comments]

W Brugger, KJ Bross, M Glatt, F Weber, R Mertelsmann, L Kanz

Blood (1994) 83 (3): 636–640.

https://doi.org/10.1182/blood.V83.3.636.636

Published: 1994

Journal Articles

Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin

W Brugger, W Mocklin, S Heimfeld, RJ Berenson, R Mertelsmann, L Kanz

Blood (1993) 81 (10): 2579–2584.

https://doi.org/10.1182/blood.V81.10.2579.2579

Published: 1993

Journal Articles

In vivo effects of interleukin-6 on thrombopoiesis in healthy and irradiated primates [see comments]

C Zeidler, L Kanz, F Hurkuck, KL Rittmann, I Wildfang, T Kadoya, T Mikayama, L Souza, K Welte

Blood (1992) 80 (11): 2740–2745.

https://doi.org/10.1182/blood.V80.11.2740.2740

Published: 1992

Journal Articles

Sequential in vivo treatment with two recombinant human hematopoietic growth factors (interleukin-3 and granulocyte-macrophage colony- stimulating factor) as a new therapeutic modality to stimulate hematopoiesis: results of a phase I study

A Ganser, A Lindemann, OG Ottmann, G Seipelt, U Hess, G Geissler, L Kanz, J Frisch, G Schulz, F Herrmann

Blood (1992) 79 (10): 2583–2591.

https://doi.org/10.1182/blood.V79.10.2583.2583

Published: 1992

Journal Articles

Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony- stimulating factor following polychemotherapy with etoposide, ifosfamide, and cisplatin [see comments]

W Brugger, K Bross, J Frisch, P Dern, B Weber, R Mertelsmann, L Kanz

Blood (1992) 79 (5): 1193–1200.

https://doi.org/10.1182/blood.V79.5.1193.1193

Published: 1992

Journal Articles

Fibrinogen gamma-chain mRNA is not detected in human megakaryocytes

W Lange, A Luig, G Dolken, R Mertelsmann, L Kanz

Blood (1991) 78 (1): 20–25.

https://doi.org/10.1182/blood.V78.1.20.20

Published: 1991

Journal Articles

Lymphokine(s) from isolated T lymphocyte subpopulations support multilineage hematopoietic colony and megakaryocytic colony formation

L Kanz, GW Lohr, AA Fauser

Blood (1986) 68 (5): 991–995.

https://doi.org/10.1182/blood.V68.5.991.991

Published: 1986

Journal Articles

Cytotoxic T-cell clones derived from pluripotent stem cells (CFU-GEMM) of patients with Hodgkin's lymphoma

AA Fauser, HA Neumann, KG Bross, L Kanz, GW Lohr

Blood (1982) 60 (6): 1317–1320.

https://doi.org/10.1182/blood.V60.6.1317.1317

Published: 1982

NARROW

R-CHOP Versus R-FC Followed by Maintenance with Rituximab Versus Interferon-Alfa: Outcome of the First Randomized Trial for Elderly Patients with Mantle Cell Lymphoma

Reduction of Combined Modality Treatment Intensity in Early Stage Hodgkin’s Lymphoma: Interim Analysis of the HD 10 Trial of the GHSG.

Ex vivo expansion of CD34+ peripheral blood progenitor cells: implications for the expansion of contaminating epithelial tumor cells

Developmental regulation of myeloid gene expression and demethylation during ex vivo culture of peripheral blood progenitor cells

Detection of cytomegalovirus DNA in CD34+ cells from blood and bone marrow

Maintenance of transplantation potential in ex vivo expanded CD34(+)- selected human peripheral blood progenitor cells

Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin

Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors [see comments]

Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin

In vivo effects of interleukin-6 on thrombopoiesis in healthy and irradiated primates [see comments]

Sequential in vivo treatment with two recombinant human hematopoietic growth factors (interleukin-3 and granulocyte-macrophage colony- stimulating factor) as a new therapeutic modality to stimulate hematopoiesis: results of a phase I study

Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony- stimulating factor following polychemotherapy with etoposide, ifosfamide, and cisplatin [see comments]

Fibrinogen gamma-chain mRNA is not detected in human megakaryocytes

Lymphokine(s) from isolated T lymphocyte subpopulations support multilineage hematopoietic colony and megakaryocytic colony formation

Cytotoxic T-cell clones derived from pluripotent stem cells (CFU-GEMM) of patients with Hodgkin's lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only